돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 632386생성일: 2026년 10월 25일

L-Leucine, N-((1,1-dimethylethoxy)carbonyl)- → 6-[(4-Fluoro-phenyl)-hydroxy-methyl]-pyridine-2-carboxylic acid [(S)-3-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-butyl]-amide

https://huagongshe.com/reaction/632386

반응식

참여 물질

역할이름HCID투입량
반응물L-Leucine, N-((1,1-dimethylethoxy)carbonyl)-HCID 83170—
반응물6-((4-Fluorophenyl)(hydroxy)methyl)picolinic acidHCID 71087341—
반응물(S)-5-methyl-alpha-(2-methylpropyl)-1,2,4-oxadiazole-3-methanamine hydrochlorideHCID 71087826—
생성물6-[(4-Fluoro-phenyl)-hydroxy-methyl]-pyridine-2-carboxylic acid [(S)-3-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-butyl]-amideHCID 71105702—

반응 단계

The title compound was synthesized in analogy to Example 1, using 6-((4-fluorophenyl)(hydroxy)methyl)picolinic acid and (S)-5-methyl-α-(2-methylpropyl)-1,2,4-oxadiazole-3-methanamine hydrochloride (which was prepared from (2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid (CAN 13139-15-6) in analogy to the procedures described in Example 38 a to e) as starting materials. MS (EI): m/e=399.2 [M+H]+.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09321727B2
출처 데이터셋uspto-grants-2016_04
ORD IDord-e0c2caf64fa344c1bcbc2e0178d3496f
출처 메모uspto-grants-2016_04